Related Experiment Video
Updated: Dec 10, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.0K
Monocusp Valves Do Not Improve Early Operative Mortality in Tetralogy of Fallot: A Meta-Analysis.
Mark N Awori1, Jonathan A Awori2, Nikita P Mehta1
1Department of Surgery, School of Medicine, 108330University of Nairobi, Kenyatta National Hospital, Nairobi, Kenya.
World Journal for Pediatric & Congenital Heart Surgery
|August 28, 2020
Summary
Monocusp valves may not reduce early death in pediatric tetralogy of Fallot repair. A meta-analysis of 12 studies found no significant difference in operative mortality between patients with and without these specialized valves.
Area of Science:
- Pediatric Cardiac Surgery
- Congenital Heart Defects
- Surgical Innovation
Background:
- Tetralogy of Fallot is a complex congenital heart defect requiring surgical repair in infancy.
- Monocusp valves are hypothesized to improve outcomes in Tetralogy of Fallot repair.
- Evidence from randomized clinical trials is lacking.
Purpose of the Study:
- To evaluate the effectiveness of monocusp valves in reducing operative mortality in pediatric Tetralogy of Fallot repair.
- To synthesize existing evidence from observational studies.
Main Methods:
- Systematic literature search of PubMed, Cochrane Library, and Google Scholar.
- Meta-analysis of 12 observational studies.
- Comparison of operative mortality in pediatric patients undergoing Tetralogy of Fallot repair with and without monocusp valves.
Main Results:
- Operative mortality was compared in 695 pediatric patients.
- No statistically significant difference in operative mortality was found between the monocusp valve group and the control group.
- The use of monocusp valves did not appear to reduce early operative mortality.
Conclusions:
- Monocusp valves may not offer a significant advantage in reducing operative mortality for pediatric Tetralogy of Fallot repair.
- Further research, potentially including randomized controlled trials, is needed to definitively establish the role of monocusp valves.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
149
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
149
01:25Mitral Regurgitation III: Medical Management
169
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
169
01:22Mitral Stenosis I: Introduction
215
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
215
01:27Mitral Stenosis IV: Nursing Management
186
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
186
01:22Mitral Valve Prolapse II: Assessment and Management
226
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
226
01:25Aortic Regurgitation III: Medical Management
222
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
222